The cost of vibegron can vary significantly depending on factors such as dosage, insurance coverage, and pharmacy.
How Much Does Gemtesa Cost?
A 30-day supply of Gemtesa (vibegron) with a retail price of approximately $500 to $600 is available. However, individuals with commercial insurance may pay as little as $0 for a prescription through a savings card program offered by the manufacturer, Urovant Sciences. Those without insurance or with high-deductible plans might face the full retail cost, though patient assistance programs could offer some relief.
Can You Get Vibegron Cheaper?
Exploring prescription discount cards and coupons can lead to lower out-of-pocket costs for Gemtesa. Manufacturer-sponsored savings programs can also substantially reduce the price for eligible patients. For those without insurance, inquiring about patient assistance programs through Urovant Sciences is a recommended step.
When Does the Vibegron Patent Expire?
The primary patents for vibegron are expected to expire in the mid-2030s. For example, U.S. Patent No. 11,254,596, which covers certain forms of vibegron, is listed with an expiration date of May 15, 2037, according to DrugPatentWatch.com [1]. However, patent landscapes are complex and can involve multiple patents covering different aspects of a drug, including manufacturing processes, formulations, and methods of use.
Are There Generic Versions of Vibegron Available?
As of now, generic versions of vibegron are not commercially available. The exclusivity period granted by patents, coupled with the time required for regulatory approval of generic equivalents, means that generic competition is not anticipated until after the expiration of key patents [1].
What is Gemtesa Used For?
Gemtesa is a medication prescribed to treat adults with overactive bladder (OOB) who experience symptoms such as urinary urgency, frequency, and incontinence [2]. It works by relaxing the bladder muscle, which helps to increase bladder capacity and reduce the sudden urge to urinate.
What are the Side Effects of Vibegron?
Common side effects associated with vibegron include headache, nasopharyngitis (common cold symptoms), and diarrhea [2]. More serious, though less common, side effects can include urinary tract infections and an increased risk of urinary retention in certain patient populations.
Sources:
[1] DrugPatentWatch.com. (n.d.). Vibegron Patent Expiration. Retrieved from https://drugpatentwatch.com/
[2] Urovant Sciences. (n.d.). Gemtesa (vibegron) Prescribing Information. Retrieved from https://www.gemtesa.com/